First Patient Treated in Test of OLT38, a Dye to Detect Ovarian Cancer Tissue During Surgery

First Patient Treated in Test of OLT38, a Dye to Detect Ovarian Cancer Tissue During Surgery
A Phase 3 clinical trial testing a special dye that “lights up” ovarian tumor tissue during surgery has treated its first participant, On Target Laboratories announced. The dye, called OTL38, is designed to make removal of cancerous tissue more complete and increase patients’ survival. “Treating our first patient in a Phase 3 trial is a major

Knowledge is power when living with ovarian cancer.

Get access to the web’s leading Ovarian Cancer news & insights for as little as 16¢/day.
Subscribe or to access all post and page content.

Leave a Comment

Your email address will not be published. Required fields are marked *